Hindy, G, Tyrrell, D J, Vasbinder, A, Wei, C, Presswalla, F, Wang, H, Blakely, P K, Ozel, A B, Graham, S E, Holton, G H, Dowsett, J, Fahed, A C, Amadi, K-M, Erne, G K, Tekumulla, A, Ismail, A, Launius, C, Sotoodehnia, N, Pankow, J S, Thørner, L W, Erikstrup, C, Pedersen, O B, Banasik, K, Brunak, S, Ullum, H, Eugen-Olsen, J, Ostrowski, S R, Haas, M E, Nielsen, J B, Lotta, L A, Engström, G, Melander, O, Orho-Melander, M, Zhao, L, Murthy, V L, Pinsky, D J, Willer, C J, Heckbert, S R, Reiser, J, Goldstein, D R, Desch, K C & Hayek, S S 2022, ' Clinical, genetic, and experimental increase in soluble urokinase plasminogen activator receptor levels promotes atherosclerosis ', Journal of Clinical Investigation, vol. 132, no. 24, e158788 . https://doi.org/10.1172/JCI158788
Circulation: Genomic and Precision Medicine, 13(3):e002872. Lippincott Williams and Wilkins Ltd. Circulation 13(3), 168-271 (2020). doi:10.1161/CIRCGEN.119.002872 Circulation. Genomic and precision medicine, 13(3):e002872. LIPPINCOTT WILLIAMS & WILKINS CHARGE Inflammation Working Group 2020, ' Interleukin-6 Signaling Effects on Ischemic Stroke and Other Cardiovascular Outcomes : A Mendelian Randomization Study ', Circulation: Genomic and Precision Medicine, vol. 13, no. 3, e002872, pp. E002872 . https://doi.org/10.1161/CIRCGEN.119.002872 Circulation. Genomic and Precision Medicine